I have been wondering for a while why it has taken so long for Ariad to get the 113 trial started.
They've never explained this, but my assumption is that they are waiting for a long-term animal tox study. Given they started talking about this drug so long ago, I think it must have been a financing issue that delayed it - if only they had abandoned their stupid patent suit they would have saved more than enough to pay for it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.